Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Purinergic receptors

D Malec1

  • 1Department of Pharmacodynamics, Medical Academy, Lublin, Poland.

Polish Journal of Pharmacology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

This paper characterizes purinergic receptors, specifically P1 (nucleoside) and P2 (nucleotide) receptors. It details their subtypes, locations, and roles in biological processes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A closer look at combining data among a small number of binomial experiments.

Statistics in medicine·2001
Same author

Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats.

Polish journal of pharmacology·2001
Same author

Model-based small area estimates of overweight prevalence using sample selection adjustment.

Statistics in medicine·1999
Same author

Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists.

Polish journal of pharmacology·1998
Same author

Influence of adenosinergic drugs on ethanol withdrawal syndrome in rats.

Polish journal of pharmacology·1996
Same author

Chemical and pharmacological properties of new tetrahydropyrimido-[2,1-f]-purines.

Die Pharmazie·1995
Same journal

Abstracts of the 8th Conference on Progress in Etiopathogenesis of Seizures. Lublin, Poland, 21 November 2003.

Polish journal of pharmacology·2005
Same journal

Influence of beta-adrenergic antagonists on tear secretion in children.

Polish journal of pharmacology·2005
Same journal

Intraamygdaloid administration of BIBO 3304 increases water intake and extends anxiolytic effects.

Polish journal of pharmacology·2005
Same journal

Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.

Polish journal of pharmacology·2005
Same journal

Effects of chronic treatment with classic and newer antidepressants and neuroleptics on the activity and level of CYP2D in the rat brain.

Polish journal of pharmacology·2005
Same journal

Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.

Polish journal of pharmacology·2005
See all related articles

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • Purinergic signaling involves extracellular nucleotides and nucleosides.
  • These signaling molecules act through specific cell surface receptors.
  • Understanding these receptors is crucial for various physiological processes.

Purpose of the Study:

  • To characterize purinergic receptors.
  • To describe the subclassification of P1 and P2 receptors.
  • To outline the distribution and functions of these receptors.

Main Methods:

  • Literature review and synthesis.
  • Analysis of existing data on purinergic receptor subtypes.
  • Comparative description of P1 and P2 receptor families.

Related Experiment Videos

Main Results:

  • Detailed subclassification of P1 (adenosine) receptors (A1, A2A, A2B, A3).
  • Overview of P2 receptors, divided into ionotropic (P2X) and metabotropic (P2Y) subtypes.
  • Summary of the diverse tissue distribution and physiological functions.

Conclusions:

  • Purinergic receptors (P1 and P2) represent a complex signaling system.
  • Their diverse subtypes, distribution, and functions highlight their importance in health and disease.
  • Further research into purinergic signaling pathways holds therapeutic potential.